Target diseaseRotator Cuff Injury, Acute Postoperative Pain After Arthroscopic Rotator Cuff Repair of Shoulder
Conditions
Interventions
Control Group(Sufentanil Group):Sufentanil Intravenous Patient-Controlled Analgesia (PCIA)
Experimental Group(Hydromorphone Group):Hydromorphone Intravenous Patient-Controlled Analgesia (PCIA)
Sponsors
The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with rotator cuff injury and scheduled for elective arthroscopic rotator cuff repair, aged 18 to 75 years, with no gender restriction; 2.ASA physical status class ? to ?, with no severe dysfunction of the heart, liver, kidney, lung or other vital organs; 3.Clear consciousness, normal communication ability, and able to cooperate with pain assessment, patient-controlled analgesia pump operation and postoperative rehabilitation training; 4.Patients and their family members have given informed consent, voluntarily participated in this study, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with hypersensitivity to hydromorphone, opioids, or adjuvant medications used in this study; 2.Patients with a history of opioid abuse or long-term use of analgesics; 3.Patients complicated with coagulation disorders, mental illness or cognitive dysfunction; 4.Patients with severe cardiopulmonary insufficiency or hepatic and renal dysfunction; 5.Pregnant or lactating women; 6.Patients who have participated in other clinical studies within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood oxygen saturation, heart rate, mean arterial pressure;Bruggrmann Comfort Scale (BCS) Score;Visual Analogue Scale (VAS) Pain Score at Rest;Ramsay Sedation Scale Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative Sufentanil and Remifentanil Dosage;Demographic Baseline Characteristics at Enrollment (Age, Gender, Height, Weight, BMI, etc.);Time to First Ambulation and Time to First Flatus Postoperatively;Postoperative Hospital Length of Stay;Postoperative Hospital Anxiety and Depression Scale (HAD) Score;Postoperative Quality of Recovery-15 (QoR-15) Score;Total PCIA Presses and Effective PCIA Presses;Time to First Rescue Analgesia and Number of Rescue Analgesic Episodes within 48 Hours Postoperatively;Incidence of Adverse Reactions (Nausea and Vomiting, Dizziness and Drowsiness, Pruritus, Hallucinations and Delirium, Respiratory Depression with SpO?<90%); | — |
Countries
China
Contacts
Public ContactQi Fengling
The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Outcome results
None listed